Integral Ad Science Holding Corp. (NASDAQ:IAS) Shares Sold by Clearbridge Investments LLC

Clearbridge Investments LLC cut its holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 6.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,729,420 shares of the company's stock after selling 187,007 shares during the quarter. Clearbridge Investments LLC owned 1.68% of Integral Ad Science worth $28,495,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of IAS. Vanguard Group Inc. boosted its position in shares of Integral Ad Science by 2.3% during the 4th quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock worth $94,467,000 after purchasing an additional 205,562 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Integral Ad Science by 6.4% during the third quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company's stock worth $19,836,000 after buying an additional 110,149 shares in the last quarter. JPMorgan Chase & Co. grew its position in Integral Ad Science by 47.6% during the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock worth $7,756,000 after buying an additional 231,271 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Integral Ad Science by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 603,848 shares of the company's stock valued at $6,304,000 after buying an additional 7,941 shares in the last quarter. Finally, Invenomic Capital Management LP lifted its position in shares of Integral Ad Science by 57.4% during the 3rd quarter. Invenomic Capital Management LP now owns 585,309 shares of the company's stock valued at $6,327,000 after acquiring an additional 213,488 shares during the period. Institutional investors and hedge funds own 95.78% of the company's stock.

Integral Ad Science Trading Down 3.2 %

Shares of IAS traded down $0.23 on Friday, hitting $7.04. 1,599,212 shares of the stock traded hands, compared to its average volume of 1,138,431. The firm has a market capitalization of $1.15 billion, a P/E ratio of 35.20, a P/E/G ratio of 1.06 and a beta of 1.53. The company has a quick ratio of 3.71, a current ratio of 3.71 and a debt-to-equity ratio of 0.07. Integral Ad Science Holding Corp. has a 1 year low of $6.97 and a 1 year high of $13.62. The stock's 50 day moving average is $9.77 and its two-hundred day moving average is $10.43.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.03). The business had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. Integral Ad Science's revenue for the quarter was up 13.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.06 EPS. As a group, sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on IAS shares. Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Oppenheimer restated an "outperform" rating on shares of Integral Ad Science in a research report on Friday, February 28th. Scotiabank initiated coverage on shares of Integral Ad Science in a research report on Friday, February 28th. They issued a "sector perform" rating and a $12.00 price objective on the stock. Barclays restated an "equal weight" rating on shares of Integral Ad Science in a report on Friday, February 28th. Finally, Robert W. Baird reaffirmed a "neutral" rating and issued a $9.00 price target (down previously from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat, Integral Ad Science presently has a consensus rating of "Moderate Buy" and a consensus price target of $14.45.

Insider Buying and Selling at Integral Ad Science

In other Integral Ad Science news, CEO Lisa Utzschneider sold 12,448 shares of the stock in a transaction that occurred on Tuesday, February 4th. The shares were sold at an average price of $10.61, for a total transaction of $132,073.28. Following the transaction, the chief executive officer now owns 278,650 shares of the company's stock, valued at $2,956,476.50. This trade represents a 4.28 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold 19,025 shares of company stock worth $195,116 in the last 90 days. 2.00% of the stock is owned by company insiders.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.